IFN-γ Licensing Does Not Enhance the Reduced Immunomodulatory Potential and Migratory Ability of Differentiation-Induced Porcine Bone Marrow-Derived Mesenchymal Stem Cells in an In Vitro Xenogeneic Application

IFN-γ licensing to mesenchymal stem cells (MSCs) is applied to enhance the therapeutic potential of MSCs. However, although the features of MSCs are affected by several stimuli, little information is available on changes to the therapeutic potential of IFN-γ-licensed differentiated MSCs during xenog...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Hyeon-Jeong, Kim, Hwan-Deuk, Jo, Chan-Hee, Bok, Eun-Yeong, Kim, Saet-Byul, Lee, Sung-Lim, Jang, Min, Bae, Seul-Gi, Yun, Sung-Ho, Kim, Seung-Joon, Rho, Gyu-Jin, Lee, Won-Jae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437647/
https://www.ncbi.nlm.nih.gov/pubmed/34527737
http://dx.doi.org/10.1155/2021/4604856

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8437647/
https://www.ncbi.nlm.nih.gov/pubmed/34527737
http://dx.doi.org/10.1155/2021/4604856

Ejemplares similares